Alector LLC

William Monteith

Arnon Rosenthal

Seung-Joo Lee

Helen Lam

Kate Monroe

Francesca Avogadri-Connors

Herve Rhinn

Francesca Avogadri-connors

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-Siglec-7 antibodies and methods of use thereof

The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.

Anti-CD33 antibodies and methods of use thereof

Anti-siglec-7 antibodies and methods of use thereof

Growing community of inventors

San Francisco, CA, United States of America

William Monteith